Why Attend?

Last Year’s Agenda
CLE

This year’s conference is going virtual! An entirely virtual format will enable innovative learning opportunities, increased schedule flexibility, and a new level of interaction between regulatory practitioners, industry experts, and government officials. Speakers will analyze the latest commercial issues related to advertising and promotion of human and animal drugs, medical devices, and biologics.

Practical Takeaways: Sessions will explore updated government agency enforcement trends, competitor actions, the current state of unapproved use promotion, patient engagement, management of risk in the current climate, and the increasing challenges of various direct-to-consumer marketing platforms.

Government Speakers: Representatives from various FDA Centers, the Federal Trade Commission, the Department of Health and Human Services Inspector General, and the Department of Justice will provide the latest information on policy, enforcement, and future initiatives.

Peer Interaction: The conference will prioritize virtual learning, engagement, and networking with fellow legal, regulatory, and marketing experts.

Register

Industry & Firms

$1399
  • +$400 for non-members

Non-Profit

$699
  • +$100 for non-members

Government

$699
  • +$100 for non-members

Academic

$699
  • +$100 for non-members

Student

$99
  • full-time students only
REGISTER NOW

 

Internet Explorer and Microsoft Edge are not supported by the checkout process.

Please use Chrome, Firefox, or Safari.  If you are unable to use these browsers, please contact us at 202-371-1420 or [email protected] and we will assist you.

Are You New to Advertising and Promotion?

Add the training course, Introduction to Advertising and Promotion for Medical Products, to your conference registration to gain a comprehensive overview of the laws and regulations affecting the medical products industries. Register for both the conference and course to save $100 off the combined fees.

To ensure that FDLI is able to provide you with a seat, materials, and meals, please register for programs at least 48 hours in advance. While onsite registration is available on a “space-available” basis; late registrants are not guaranteed materials or meals.

You can transfer your registration to another person at your organization for no cost by notifying us of the change. If you notify FDLI in writing at least five business days prior to the meeting, you can cancel your registration for a full refund (less a $75 fee). Refunds will be applied against the original form of payment.  

Our event policies are listed here. If you should have any further questions, please contact us at [email protected] or 800-956-6293.

Sponsors

Sponsorship opportunities are available. Please let us know if you would like more information.

 

Gold Sponsor

Gold Sponsor

Gold Sponsor

Gold Sponsor

 

Silver Sponsor

 

Silver Sponsor

Silver Sponsor

Silver Sponsor

 

Silver Sponsor

Silver Sponsor

Call for Proposals

FDLI and the Conference Planning Committee thanks those who participated in the Call for Proposals. The input received from industry stakeholders helps us plan a timely program. If you submitted a proposal, you will be notified of the status of your proposal in July.

 

Planning Committee

Fadwa Almanakly, Bayer Healthcare Pharmaceuticals
Heather Banuelos, (Co-Chair), King & Spalding LLP 
Madhavi Bellamkonda, Abbott Vascular
Blythe Buchanan, Biogen, Inc.
Rebecca Burnett, Framework Solutions
Dale Cooke, PhillyCooke Consulting
Mary Ellen Dronitsky, Northeastern University
Virginia Foley, Opus Regulatory Inc
Mark Garsombke, Hall, Render, Killian, Heath & Lyman P.C.
Bryant M. Godfrey, Arnold & Porter LLP
Mark C. Levy, Eckert Seamans Cherin & Mellott, LLC
Lauren A. Miller, Otsuka America Pharmaceutical, Inc.
Cassie Scherer, Medtronic
Dolores M. Shank-Samiec, (Co-Chair)Merck & Co., Inc. 
Michael Francis Smith, Michael F. Smith Law, PLLC